Down syndrome-associated Alzheimer's disease (DS-ad)

Clinical trials for Down syndrome-associated Alzheimer's disease (DS-ad) explained in plain language.

Never miss a new study

Get alerted when new Down syndrome-associated Alzheimer's disease (DS-ad) trials appear

Sign up with your email to follow new studies for Down syndrome-associated Alzheimer's disease (DS-ad), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for Alzheimer's in down syndrome: drug trial launches

Disease control Recruiting now

This study tests a drug called mivelsiran in 58 adults with Down syndrome who have early-stage Alzheimer's. Participants receive either the drug or a placebo via injection into the spine every few months for two years. The goal is to see if the drug can reduce brain changes linke…

Matched conditions: DOWN SYNDROME-ASSOCIATED ALZHEIMER'S DISEASE (DS-AD)

Phase 2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control

Last updated Sep 06, 2026 00:00 UTC

Down syndrome-associated Alzheimer's disease (DS-ad)

Get alerted when new Down syndrome-associated Alzheimer's disease (DS-ad) trials appear

New hope for Alzheimer's in down syndrome: drug trial launches